Join SART

Join SART Thank you for your interest in joining SART.  Information regarding SART membership can be found below: *Please note the membership review and approval process can take up to 30

Data_Being_Validated

Data Being Validated This clinic is a SART member in good standing. Their IVF data has been removed while undergoing revisions and data validation.

Find A Clinic

_blank

National Summary

Web Terms & Conditions of Use

ASRM/SART Terms & Conditions of Use PLEASE READ THESE TERMS AND CONDITIONS OF USE CAREFULLY BEFORE USING THE ASRM or SART WEBSITE. By using the ASRM/SART Website (sometimes referred to as the

Nondiscrimination Policy

ASRM/SART Nondiscrimination Policy The American Society for Reproductive Medicine and Society for Assisted Reproductive Technology value and promote diversity among its members, officers and

Live birth outcomes after euploid transfer: autologous vs. donor oocyte embryos in patients aged > 35 years

To compare live birth outcomes between euploid donor oocyte and euploid autologous oocyte–derived embryos among patients with advanced maternal age.

Alterations in the ultrasound appearance of seminiferous tubules after gonadotropin treatment in patients with azoospermia because of hypogonadotropic hypogonadism

To demonstrate the relationship between ultrasound (US) changes in seminiferous tubules during gonadotropin replacement therapy and spermatogenic progression in patients with azoospermia because

Progestin-suppressed in vitro fertilization cycles yield similar outcomes to traditional protocols in patients with diminished ovarian reserve

To evaluate the effectiveness of the progestin-suppressed in vitro fertilization (IVF) stimulation protocol in patients with diminished ovarian reserve.

Reproductive impact of immune checkpoint inhibitor therapy in women with melanoma

To study the reproductive impact of immune checkpoint inhibitor (ICI) therapy in cis-females with melanoma.